A. Michael Crider

1.2k total citations
55 papers, 1.0k citations indexed

About

A. Michael Crider is a scholar working on Organic Chemistry, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, A. Michael Crider has authored 55 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Organic Chemistry, 23 papers in Molecular Biology and 13 papers in Cellular and Molecular Neuroscience. Recurrent topics in A. Michael Crider's work include Neuroendocrine Tumor Research Advances (8 papers), Receptor Mechanisms and Signaling (8 papers) and Neuroscience and Neuropharmacology Research (7 papers). A. Michael Crider is often cited by papers focused on Neuroendocrine Tumor Research Advances (8 papers), Receptor Mechanisms and Signaling (8 papers) and Neuroscience and Neuropharmacology Research (7 papers). A. Michael Crider collaborates with scholars based in United States, Denmark and Canada. A. Michael Crider's co-authors include James P. Stables, Rajeev Gokhale, K. Witt, Milind M. Narurkar, Mansoor A. Khan, Karin E. Sandoval, Christine N. Hinko, Milton J. Kornet, Michael Ankersen and Carsten E. Stidsen and has published in prestigious journals such as PLoS ONE, Brain Research and The FASEB Journal.

In The Last Decade

A. Michael Crider

53 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Michael Crider United States 17 542 378 159 155 105 55 1.0k
Hassan H. Farag Egypt 20 517 1.0× 313 0.8× 121 0.8× 115 0.7× 114 1.1× 43 1.0k
Ronald C. Bernotas United States 19 951 1.8× 549 1.5× 130 0.8× 75 0.5× 91 0.9× 43 1.2k
Ilya Okun United States 22 711 1.3× 578 1.5× 113 0.7× 121 0.8× 66 0.6× 66 1.3k
Tomoyuki Ohe Japan 23 348 0.6× 429 1.1× 83 0.5× 160 1.0× 359 3.4× 61 1.3k
Andrew Pike United Kingdom 19 917 1.7× 558 1.5× 122 0.8× 370 2.4× 55 0.5× 26 1.8k
Takashi Inaba Japan 18 539 1.0× 385 1.0× 226 1.4× 135 0.9× 39 0.4× 50 1.1k
David G. Melillo United States 14 440 0.8× 289 0.8× 132 0.8× 158 1.0× 127 1.2× 37 939
Krzysztof Kamiński Poland 23 746 1.4× 431 1.1× 139 0.9× 289 1.9× 42 0.4× 80 1.3k
Maria Modica Italy 24 629 1.2× 893 2.4× 188 1.2× 171 1.1× 51 0.5× 76 1.6k
Serena Scapecchi Italy 20 456 0.8× 750 2.0× 205 1.3× 195 1.3× 423 4.0× 82 1.3k

Countries citing papers authored by A. Michael Crider

Since Specialization
Citations

This map shows the geographic impact of A. Michael Crider's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Michael Crider with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Michael Crider more than expected).

Fields of papers citing papers by A. Michael Crider

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Michael Crider. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Michael Crider. The network helps show where A. Michael Crider may publish in the future.

Co-authorship network of co-authors of A. Michael Crider

This figure shows the co-authorship network connecting the top 25 collaborators of A. Michael Crider. A scholar is included among the top collaborators of A. Michael Crider based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Michael Crider. A. Michael Crider is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Crider, A. Michael, Karin E. Sandoval, William L. Neumann, et al.. (2024). 3-Thio-3,4,5-trisubstituted-1,2,4-triazoles: high affinity somatostatin receptor-4 agonist synthesis and structure–activity relationships. RSC Medicinal Chemistry. 16(2). 945–960. 1 indexed citations
2.
Neumann, William L., Karin E. Sandoval, Susan A. Farr, et al.. (2021). Synthesis and structure–activity relationships of 3,4,5-trisubstituted-1,2,4-triazoles: high affinity and selective somatostatin receptor-4 agonists for Alzheimer's disease treatment. RSC Medicinal Chemistry. 12(8). 1352–1365. 6 indexed citations
3.
Schober, Joseph, et al.. (2021). NNC 26-9100 increases Aβ1-42 phagocytosis, inhibits nitric oxide production and decreases calcium in BV2 microglia cells. PLoS ONE. 16(7). e0254242–e0254242. 8 indexed citations
4.
Crider, A. Michael, et al.. (2018). Synthesis of 3-(3-hydroxyphenyl)pyrrolidine dopamine D3 receptor ligands with extended functionality for probing the secondary binding pocket. Bioorganic & Medicinal Chemistry Letters. 28(10). 1897–1902. 3 indexed citations
5.
Kuzhikandathil, Eldo V., et al.. (2015). Identification of key residues involved in the activation and signaling properties of dopamine D3 receptor. Pharmacological Research. 99. 174–184. 5 indexed citations
6.
Sandoval, Karin E., Susan A. Farr, William A. Banks, et al.. (2010). Chronic peripheral administration of somatostatin receptor subtype-4 agonist NNC 26-9100 enhances learning and memory in SAMP8 mice. European Journal of Pharmacology. 654(1). 53–59. 19 indexed citations
7.
Crider, A. Michael & K. Witt. (2007). Somatostatin sst4 Ligands: Chemistry and Pharmacology. Mini-Reviews in Medicinal Chemistry. 7(3). 213–220. 15 indexed citations
8.
Crider, A. Michael. (2003). Somatostatin receptor agonists and antagonists. Expert Opinion on Therapeutic Patents. 13(9). 1427–1441. 2 indexed citations
9.
Crider, A. Michael. (2002). Recent Advances in the Development of Nonpeptide Somatostatin Receptor Ligands. Mini-Reviews in Medicinal Chemistry. 2(5). 507–517. 12 indexed citations
10.
Crider, A. Michael & Mark A. Scheideler. (2001). Recent Advances in the Development of Dopamine D3 Receptor Agonists and Antagonists. Mini-Reviews in Medicinal Chemistry. 1(1). 89–99. 13 indexed citations
11.
Crider, A. Michael, et al.. (2001). Synthesis and structure–activity relationships of potential anticonvulsants based on 2-piperidinecarboxylic acid and related pharmacophores. European Journal of Medicinal Chemistry. 36(3). 265–286. 141 indexed citations
12.
Crider, A. Michael, et al.. (1999). 2-Pyridylthioureas: Novel Nonpeptide Somatostatin Agonists with SST4 Selectivity. Current Pharmaceutical Design. 5(4). 255–263. 14 indexed citations
13.
Hinko, Christine N., A. Michael Crider, Caren L. Steinmiller, et al.. (1996). Anticonvulsant Activity of Novel Derivatives of 2- and 3-Piperidinecarboxylic Acid in Mice and Rats. Neuropharmacology. 35(12). 1721–1735. 9 indexed citations
14.
Narurkar, Milind M., et al.. (1994). Morpholinoalkyl Ester Prodrugs of Diclofenac: Synthesis,In VitroandIn VivoEvaluation. Journal of Pharmaceutical Sciences. 83(5). 644–648. 51 indexed citations
15.
16.
Klein, C., et al.. (1993). cis-1,2,3a,4,5,9b-Hexahydro-3H-benz[e] indoles: Synthesis and In Vitro Binding Affinity at Dopamine D1 and D2 Receptors. Journal of Pharmaceutical Sciences. 82(3). 334–339. 6 indexed citations
17.
Narurkar, Milind M., et al.. (1993). Synthesis and Evaluation of Morpholinoalkyl Ester Prodrugs of Indomethacin and Naproxen. Pharmaceutical Research. 10(8). 1191–1199. 48 indexed citations
18.
Gokhale, Rajeev, et al.. (1990). Hydrolysis of Nipecotic Acid Phenyl Esters. Journal of Pharmaceutical Sciences. 79(1). 63–65. 7 indexed citations
19.
Hinko, Christine N., A. Michael Crider, & J. D. Wood. (1988). A comparison of prodrug esters of nipecotic acid. Neuropharmacology. 27(5). 475–483. 10 indexed citations
20.
Crider, A. Michael, et al.. (1980). Synthesis and anticancer activity of nitrosourea derivatives of phensuximide. Journal of Medicinal Chemistry. 23(3). 324–326. 82 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hassan H. Farag Breakdown of academic impact, for papers by Ronald C. Bernotas Breakdown of academic impact, for papers by Ilya Okun Breakdown of academic impact, for papers by Tomoyuki Ohe Breakdown of academic impact, for papers by Andrew Pike Breakdown of academic impact, for papers by Takashi Inaba Breakdown of academic impact, for papers by David G. Melillo Breakdown of academic impact, for papers by Krzysztof Kamiński Breakdown of academic impact, for papers by Maria Modica Breakdown of academic impact, for papers by Serena Scapecchi
Rankless by CCL
2026